Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
Review (6 cohort studies, n=179,158) found influenza vaccination was associated with a lower risk of all-cause mortality (HR=0.83; 95%CI 0.76 to 0.91; I2=75%). However, evidence statements are based on very low grade quality evidence. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 20, 2020 Category: Consumer Health News Source Type: news

Hypertonic Saline Promising in Diuretic-Resistant Heart Failure Hypertonic Saline Promising in Diuretic-Resistant Heart Failure
Hypertonic saline (HS) appears to be safe and well tolerated as an adjuvant to loop diuretics in refractory acute decompensated heart failure (ADHF), according to a retrospective study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 16, 2020 Category: Pathology Tags: Cardiology News Source Type: news

These Cincinnati hospitals rank among the nation ’s best
Three hospitals in Greater Cincinnati are among the 50 best in the nation and five other local hospitals also were recognized for clinical excellence in a new ranking by the website Healthgrades. The performance of nearly 4,500 hospitals nationwide was analyzed across 32 conditions and procedures to determine recipients of America’s Best Hospitals Awards, according to Healthgrades. That included reviews of care provided for heart attack, heart failure, pneumonia, respiratory failure, sep sis and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 12, 2020 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Yale study adds to evidence of diabetes drug link to heart problems
(Yale School of Public Health) A new study published by The BMJ adds to evidence that rosiglitazone -- a drug used to treat type 2 diabetes -- is associated with increased risk of heart problems, especially heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2020 Category: International Medicine & Public Health Source Type: news

Understanding heart failure in pediatric patients
(Bentham Science Publishers) The third volume of Frontiers in Heart Failure series explains heart failure in pediatric patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2020 Category: International Medicine & Public Health Source Type: news

Meta-Analyses Link Rosiglitazone to Increased Cardiovascular Risk
THURSDAY, Feb. 6, 2020 -- Rosiglitazone seems to be associated with an increased cardiovascular risk, particularly heart failure, according to data from a systematic review and meta-analyses published online Feb. 5 in The BMJ. Joshua D. Wallach,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2020 Category: Pharmaceuticals Source Type: news

Cells to Society: Year of the Nurse / Global Impact
This study establishes baseline sociodemographic and clinical characteristics of hospitalized patients in Nepal who were experiencing heart failure.     Read more   Maternal Health ...
Source: Johns Hopkins University and Health Systems Archive - February 6, 2020 Category: Nursing Source Type: news

Another BiV Pacing Alternative? LV-Septal Pacing Enticing for CRT Another BiV Pacing Alternative? LV-Septal Pacing Enticing for CRT
The technique could have resynchronization-therapy advantages in heart failure over standard biventricular and His-bundle pacing, the latter only lately touted as a novel BiV alternative.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 5, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

High blood pressure: Working this many hours a week may increase risk of condition
HIGH blood pressure is risky business. Unnecessarily putting strain on the arteries, it can lead to aneurysms, dementia and heart failure. Now a study confirms working a certain number of hours per week could increase the chances of developing the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 5, 2020 Category: Consumer Health News Source Type: news

Abbott Continues to Show Heart with ‘Breakthrough’ Announcement
Abbott Laboratories continues to extend its list of milestones in the cardiovascular space. The Abbott Park, IL-based company has now won Breakthrough Device Designation from FDA for the in-development Fully Implantable Left Ventricular Assist System (FILVAS). FILVAS builds on the HeartMate 3 Left Ventricular Assist Device (LVAD). The technology was inherited by St. Jude Medical when it was acquired by Abbott. St. Jude inherited Heartmate 3 after it acquiredThoratec for $3.4 billion. Kevin Bourque, Divisional Vice President of Research & Development for Abbott’s Mechanical Circulatory Support portfo...
Source: MDDI - February 5, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

Red and processed meat linked to CVD and all-cause mortality
Researchers advise trying to swap red meat and processed meats for fish, seafood, nuts and legumes Related items fromOnMedica Most supplements offer no real benefit, some might increase risks WHO dietary fat guidance fails to consider crucial evidence Plant-based diet linked to lower risk of heart failure Vitamin D supplements do not confer cardiovascular protection Sweetened drinks greater risk for poor glycaemic control (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2020 Category: UK Health Source Type: news

ICDs Have Come a Long Way in 40 Years
Michel Mirowski and his colleagues gave the field of implantable cardioverter-defibrillators (ICDs) a pretty good start, but what's more impressive is how far the technology has advanced since that first human ICD implant in February 1980. In the past 40 years we've seen ICDs become dramatically smaller, longer lasting, more capable, more personalized, subcutaneous (non-transvenous), and even MRI-firendly. And that's not to mention the advanced data connectivity and monitoring capabilities that the latest technologies offer. So without further ado, let's take a look at the current ICD landscape and the companie...
Source: MDDI - February 4, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Trial examines the clinical impact of risk prediction in heart failure
YNHH currently has a clinical trial underway to learn more about improving outcomes for patients with heart failure. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 4, 2020 Category: Universities & Medical Training Source Type: news

Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
ABBOTT PARK, Ill., Feb. 4, 2020 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Imp... Devices, Cardiology, FDA Abbott, Left Ventricular Assist, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 4, 2020 Category: Pharmaceuticals Source Type: news

AHA News: Millions Are Learning to Live With Heart Failure
Title: AHA News: Millions Are Learning to Live With Heart FailureCategory: Health NewsCreated: 2/3/2020 12:00:00 AMLast Editorial Review: 2/4/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 4, 2020 Category: Cardiology Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: Millions Are Learning to Live With Heart Failure
MONDAY, Feb. 3, 2020 (American Heart Association News) -- It was almost six years to the day after Aimee Rodriguez-Zepeda completed her chemotherapy that doctors listened to her heart and gave her the bad news. " I was exhausted, " she said. " They... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 3, 2020 Category: General Medicine Source Type: news

Link between chronic kidney disease and heart failure is identified in patients
(University of Alabama at Birmingham) People with chronic kidney disease have a higher risk for heart disease and heart-disease death. Now, for the first time in humans, researchers have identified a pathological change that appears to link kidney disease to progressive heart disease. This offers a potential treatment target, which could have wide benefit because 14 percent of the US adult population has chronic kidney disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 3, 2020 Category: Biology Source Type: news

Innovations in high-risk heart failure treatments: transplants and technology
Leading medical centers, including Temple University Hospital, are finding new ways to approve more people for heart transplants, including those with coexisting health conditions. An estimated 6 million Americans — nearly equal to the population of the Delaware Valley — are living with a heart failure diagnosis. The life-threatening condition develops when the heart becomes too weak to pump adequate blood supply to support other organs in the body. Heart failure is co mmonly associated with… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Erin Bernall Source Type: news

Innovations in high-risk heart failure treatments: transplants and technology
Leading medical centers, including Temple University Hospital, are finding new ways to approve more people for heart transplants, including those with coexisting health conditions. An estimated 6 million Americans — nearly equal to the population of the Delaware Valley — are living with a heart failure diagnosis. The life-threatening condition develops when the heart becomes too weak to pump adequate blood supply to support other organs in the body. Heart failure is co mmonly associated with… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2020 Category: Biotechnology Authors: Erin Bernall Source Type: news

Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option Tendyne valve provides relief from heart failure symptoms and quality-of-life improvement in high-surgical-risk patient... Devices, Interventional, Cardiology, Regulatory Abbott, Tendyne, Transcatheter, Mitral Valve, TMVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2020 Category: Pharmaceuticals Source Type: news

New therapy may ease congestion for heart failure patients
A new therapy demonstrates that direct sodium removal (DSR) is a safer alternative to remove excess sodium from the body. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 29, 2020 Category: Universities & Medical Training Source Type: news

Common form of heart failure could be treated with already approved anticancer drug
(Temple University Health System) Thanks to new research by scientists at the Lewis Katz School of Medicine at Temple University, a drug capable of reversing a common form of heart failure known as heart failure with preserved ejection fraction (HFpEF) may soon be available. The researchers show that a drug already approved for the treatment of some forms of cancer can reverse HFpEF symptoms and improve the heart's ability to pump blood in an HFpEF animal model. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 29, 2020 Category: Cancer & Oncology Source Type: news

Gay body shaming pressure 'led to severe heart failure'
Some gay men are turning to tummy tucks and steroids to feel accepted in their community. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 29, 2020 Category: Consumer Health News Source Type: news

FDA clears Berkeley health tech startup's algorithms to detect heart problems
Berkeley health-tech startup Eko was granted FDA clearance today to take its algorithm for detecting atrial fibrillation to the market.   The algorithm, in tandem with a digital stethoscope, is meant to be used to screen for atrial fibrillation and other types of heart disease caused by heart murmurs — a condition that can result in a stroke or heart failure if left untreated. Connor Landgraf, CEO and co-founder of Eko, said it is the first in-office screening algorithm used with a stethoscope… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 28, 2020 Category: Biotechnology Authors: Brian Rinker Source Type: news

FDA clears Berkeley health tech startup's algorithms to detect heart problems
Berkeley health-tech startup Eko was granted FDA clearance today to take its algorithm for detecting atrial fibrillation to the market.   The algorithm, in tandem with a digital stethoscope, is meant to be used to screen for atrial fibrillation and other types of heart disease caused by heart murmurs — a condition that can result in a stroke or heart failure if left untreated. Connor Landgraf, CEO and co-founder of Eko, said it is the first in-office screening algorithm used with a stethoscope… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 28, 2020 Category: Pharmaceuticals Authors: Brian Rinker Source Type: news

Model Shows Transitional Care Cost-Effective in Heart Failure
MONDAY, Jan. 27, 2020 -- Transitional care services are cost-effective for the postdischarge management of older patients with heart failure, according to a study published online Jan. 28 in the Annals of Internal Medicine. Manuel R. Blum, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2020 Category: Pharmaceuticals Source Type: news

Study Shows ‘ Water Pill ’ May Help Reduce Some Autism Symptoms In Young Kids
BOSTON (CBS) — A drug that has been used to treat heart failure for decades may improve behavioral symptoms in some young children with autism. Bumetanide is a diuretic, which is used to treat the buildup of fluid in the body. Researchers in China and at the University of Cambridge looked at 83 kids between three and six years old and found that, three months later, the children treated with the diuretic scored better on a behavior scale which measures emotional response as well as verbal and non-verbal communication. They believe the drug helps nerve cells communicate more effectively by reducing the level of a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 27, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Autism Dr. Mallika Marshall Source Type: news

LV Hypertrophy May Explain Racial Disparities in Heart Failure
MONDAY, Jan. 27, 2020 -- A " malignant " subphenotype of left ventricular hypertrophy (LVH) with minimal elevations in cardiac biomarkers is associated with an increased risk for heart failure, with some of the excess risk for heart failure among... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2020 Category: Pharmaceuticals Source Type: news

Weight loss surgery may reduce the risk of heart failure and premature death
(Wiley) Compared with routine care, weight loss surgery was linked with a reduced risk of hypertension, heart failure, and early death in a study based on information from a primary care database in the UK. The findings are published in BJS (British Journal of Surgery). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

Postdischarge Mortality Up for Patients With Heart Failure
Of conditions targeted by Hospital Readmissions Reduction Program, only heart failure mortality increased (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 24, 2020 Category: Respiratory Medicine Tags: Cardiology, Pulmonology, Critical Care, Emergency Medicine, Journal, Source Type: news

Postdischarge Mortality Up for Patients With Heart Failure
FRIDAY, Jan. 24, 2020 -- Patients with heart failure, but not those with acute myocardial infarction or pneumonia, have demonstrated an increase in postdischarge 30-day mortality, according to a study published online Jan. 15 in The BMJ. Rohan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2020 Category: Pharmaceuticals Source Type: news

Researchers find drug used widely to treat eye condition has 'no benefit'
Researchers from the University of Bristol and University Hospital Southampton have found that a drug used widely to treat a common eye condition has “ no benefit ” and should no longer be used. Eplerenone, which is primarily used to treat heart failure, is currently offered widely by ophthalmologists as a treatment for central serous chorioretinopathy (CSCR) based on limited clinical data. (Source: University of Bristol news)
Source: University of Bristol news - January 24, 2020 Category: Universities & Medical Training Tags: Research, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Impulse Dynamics moving to expanded HQ after raising $80.25M
The company's working to commercialize its implantable cardiac device used to treat chronic heart failure. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2020 Category: Biotechnology Authors: Michelle Caffrey Source Type: news

New research could reduce the risk of sudden cardiac death
New research has shown that by changing the time course of voltage change early when the heart cell contracts it is possible to both withhold a potentially lethal electrical disturbance and improve the strength of cardiac contraction in heart failure at the same time. (Source: University of Bristol news)
Source: University of Bristol news - January 20, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Physiology, Pharmacology and Neuroscience; Press Release Source Type: news

New research could reduce the risk of sudden cardiac death
(University of Bristol) New research has shown that by changing the time course of voltage change early in action potential it is possible to both withhold a potentially lethal electrical disturbance and improve the strength of cardiac contraction in heart failure at the same time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 20, 2020 Category: International Medicine & Public Health Source Type: news

Mineralocorticoid Receptor Antagonists Unlikely to Induce Hypotension in HFrEF Mineralocorticoid Receptor Antagonists Unlikely to Induce Hypotension in HFrEF
Patients with heart failure with reduced ejection fraction (HFrEF) can be treated with mineralocorticoid receptor antagonists (MRAs) and are unlikely to develop hypotension as a result, an analysis of two large randomized trials reveals.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 19, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

BioCardia Fills in a Key Piece of CardiaAmp Puzzle with New Clearance
BioCardia has filled in another piece of the CardiAmp Cell Therapy puzzle with a new clearance from FDA. The San Carlos, CA-based company has received a nod from the federal agency to market the Morph DNA deflectable guide catheter. The device is used to guide the Helix Biotherapeutic Delivery System during CardiAMP cell therapy delivery in the heart. CardiAMP cell therapy uses a patient’s own (autologous) bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure to potentially stimulate the body’s natural healing response to treat heart failure. The comp...
Source: MDDI - January 17, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

How Medtronic Is & #039;Igniting Women to Lead & #039;
Medtronic has been awarded the 2020 Catalyst Award in recognition of its Medtronic Women's Network (MWN) and Women in Science and Engineering (WISE) initiatives, which the company says are key drivers of its overall inclusion and diversity strategy. Medtronic is the only medical device company selected to win the award this year. The MWN was refocused by Medtronic CEO Omar Ishrak in 2013 with the idea that diverse perspectives and people produce better decisions, better outcomes, and better business performance. The MWN has more than 15,000 members in 68 countries who gain leadership and functional experience t...
Source: MDDI - January 16, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Falls in community-dwelling older adults with heart failure: A retrospective cohort study - Lee K, Davis MA, Marcotte JE, Pressler SJ, Liang J, Gallagher NA, Titler MG.
BACKGROUND: While heart failure (HF) in older adults is associated with fall risk, little is known about this in the U.S. OBJECTIVE: To examine the independent effect of functional impairments related to HF on falls among community-dwelling older a... (Source: SafetyLit)
Source: SafetyLit - January 16, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Outcomes Superior for HM3 LVAD Regardless of Preimplant Strategy
WEDNESDAY, Jan. 15, 2020 -- For patients with advanced heart failure, the HeartMate 3 (HM3) left ventricular assist device (LVAD) is superior to the HeartMate II (HMII), regardless of whether the device is a bridge to transplant (BTT) or a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 15, 2020 Category: Pharmaceuticals Source Type: news

Hospital readmission policy did not increase patients' mortality risk
(Yale University) The Obamacare program intended to reduce the risk of patients being readmitted after hospitalizations for heart attacks, heart failure, and pneumonia has not caused an increase in mortality risk for patients in emergency departments or observational units, according to a new report. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news

Treatment of HF With Preserved EF Is a Work in Progress Treatment of HF With Preserved EF Is a Work in Progress
How to best treat patients with heart failure with preserved ejection fraction and diabetes remains a challenge.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 14, 2020 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Racial disparities in heart failure explained
(UT Southwestern Medical Center) Researchers at UT Southwestern have uncovered evidence that the higher prevalence of 'malignant' enlargement of the heart among blacks contributes to the higher incidence of heart failure in this population. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 14, 2020 Category: International Medicine & Public Health Source Type: news

Melatonin for jet lag should ‘not’ be available on the NHS
Scant evidence of it relieving symptoms, review finds Related items fromOnMedica Experts call on regulators to revisit nalmefene decision Debate goes on over valproate in pregnancy Pharma withheld faulty device info in rivaroxaban trial Draft diabetes guidance too heavily focused on cost, protests industry NSAIDs and COX 2s linked to heart failure admission (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 14, 2020 Category: UK Health Source Type: news

Executive health programs buck imaging guidelines
Executive health screening programs at major U.S. hospitals continue to provide...Read more on AuntMinnie.comRelated Reading: CT CAC linked to cardiovascular mortality in young adults Elevated CT CAC scores linked to future heart failure Cardiac risk grows with higher coronary calcium scores ACC: Physicians omit CT CAC scores in 50% of cancer cases Heart societies endorse CT CAC for risk assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2020 Category: Radiology Source Type: news

First Japanese Patients Randomized In Corvia Medical's REDUCE LAP-HF II Global Clinical Trial For Heart Failure
Pivotal study investigates the Corvia InterAtrial Shunt Device (IASD®) for heart failure TEWKSBURY, Mass., Jan. 13, 2020 -- (Healthcare Sales & Marketing Network) -- Corvia Medical, Inc., a privately-held company with a first-in-class structural he... Devices, Interventional, Cardiology Corvia Medical, InterAtrial Shunt Device, IASD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2020 Category: Pharmaceuticals Source Type: news

Patients With Acute Leukemias Have Increased Risk for Heart Failure, Study Shows
Researchers developed a risk score assessment to measure potential risk for chemotherapy-induced heart failure (Source: CancerNetwork)
Source: CancerNetwork - January 11, 2020 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news

Major Cardiovascular Diseases May Up Long-Term Risk for ESKD
FRIDAY, Jan. 10, 2020 -- Major incident cardiovascular disease events are associated with an increased risk for end-stage kidney disease (ESKD), with the highest risk for heart failure, according to a study published online Jan. 9 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2020 Category: Pharmaceuticals Source Type: news

Heart diseases raise risk for kidney failure, study finds
Researchers found that those with a history of heart failure, atrial fibrillation, coronary heart disease and stroke were 10 times more likely to develop kidney failure than those without cardiovascular disease (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 9, 2020 Category: Consumer Health News Source Type: news